Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
about
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signalsAlzheimer's disease: Targeting the Cholinergic SystemNicotinic receptor modulation to treat alcohol and drug dependenceDose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout miceIncreased neurodegeneration during ageing in mice lacking high-affinity nicotine receptorsFunctional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cellsQuantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampusNicotinic modulation of hippocampal cell signaling and associated effects on learning and memoryNicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Ca(2+) changes induced by different presynaptic nicotinic receptors in separate populations of individual striatal nerve terminals.Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex.Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.Role of the endogenous cannabinoid system in nicotine addiction: novel insights.α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons.Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulationDevelopmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neuronsTonic nicotinic transmission enhances spinal GABAergic presynaptic release and the frequency of spontaneous network activityAnxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism.CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.Nicotinic receptor-evoked hippocampal norepinephrine release is highly sensitive to inhibition by isoflurane.Nonsynaptic chemical transmission through nicotinic acetylcholine receptors.Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.Nicotinic receptor-based therapeutics and candidates for smoking cessation.Nicotine: alcohol reward interactions.Flavored e-cigarette liquids reduce proliferation and viability in the CALU3 airway epithelial cell line.Risk to human health associated with the environmental occurrence of cyanobacterial neurotoxic alkaloids anatoxins and saxitoxins.Presynaptic membrane receptor in human brainAngiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
P2860
Q26861923-61E09925-4310-4C1B-9A70-F04B48DFCEBDQ28070135-9B421E3D-6A1C-466A-A5F4-F56BE996E066Q28087047-AD87B1E6-3704-4FE1-A674-F7D151507228Q28363006-1DB1FA0F-AD00-4262-B6FF-95ED719F8F82Q28505103-D3DF7F28-EC4C-43B4-9724-4CE312CCDFC6Q28510543-D28EBD53-748F-452D-80A2-743612F954E7Q28579460-D3EB261C-7FA7-4806-98DB-6921573FD919Q30362437-D53CB4F9-DB45-442B-A7A6-171464E978CEQ30372354-A671D755-A95E-4BDC-B6B2-4BE65419E1CEQ30422037-0F86FAE1-3174-4BF2-907A-EA395BCB3FC9Q30983911-E3525203-A88F-4098-B87D-98682466988EQ33635666-F6DC6FDE-3CAF-43E3-9491-B0A67EC0C942Q34012381-869B12EC-82F9-499A-BAAE-014FF4EF4912Q34121565-33A0C695-99FD-4222-8416-521968700D0EQ35025328-3DE0ACDF-B6E5-4F1C-8957-0C3280F0FDA3Q35044784-CB1932FE-CC71-4066-898F-B09F7D0A2AABQ35216481-2EDE4A99-31CD-4E43-9EFD-E2EBB22D3E81Q35588867-EEE39F7B-7550-410F-8D0D-0C480F04ADA8Q35734746-B378AD3C-1421-427A-A047-2190F4EF06F6Q35997207-2D92EE03-28DD-4107-B717-6C0B38117A3BQ36052826-34AD5D85-0EF6-4086-9B96-D15438119127Q36063653-A3068AC4-F569-47AB-A72B-B826FBC19173Q36359759-D8B0F491-630E-4471-B6AB-B72C1BA6DA61Q36378201-21B51DE4-2391-4DD4-9DB4-A69B01D8B0B2Q36581617-69DCDC18-A51D-4540-A76E-B64E3C56A32EQ36781037-0E88076B-C0EB-4E3B-AA49-619293634080Q36900018-9E9BC969-F0C4-46DB-8F74-F37DC8728A19Q36933882-47300037-38FF-4EE9-9DE2-8E7148A2B566Q37097156-760E58BD-7A2D-458F-94A2-D4535B8F6AA2Q37129328-B1486942-DA54-4A53-ABA9-A78206D2305CQ37396979-807FC07A-37B6-4D08-9719-8F58AB957220Q37518024-6C95D0AD-4EE4-4747-B084-10EFA7408F2BQ37760463-9B444140-80EA-4AB1-8788-3CF9410871E9Q38706641-9C63FA0E-50C6-4EA1-A22E-D8F277F4A4AAQ38753504-3B45E210-D23C-4CC3-B325-6ECD1DC01ACBQ39484416-803FF7FE-E7FA-4F2F-ABC4-8B32CB377594Q40422963-2A2A6427-78F6-45E5-9AD8-D7AF164FC0EFQ41686143-43B6F3E8-C5D0-4C5E-B9D6-DF618793D3FBQ41869437-86EB8816-AD52-469C-AB0D-9DE9CDFB40A1Q42126606-34D9D196-3261-4A8F-ACEF-1617BF32A5DD
P2860
Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@ast
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@en
type
label
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@ast
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@en
prefLabel
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@ast
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@en
P2860
P1476
Release of [3H]-noradrenaline ...... triatal [3H]-dopamine release.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15232.X
P407
P577
1996-02-01T00:00:00Z